Fernando José Magro Dias


AuthID: R-000-50A

Confirmed Publications: 274



51
TITLE: Inflammatory Bowel Disease in migrant populations – a narrative review
AUTHORS: Maria Manuela Estevinho; Diogo José M Lopes; Miguel Torre Souto; Fernando Magro ;
PUBLISHED: 2020, SOURCE: Current Drug Targets, VOLUME: 21
INDEXED IN: CrossRef
IN MY: ORCID
52
TITLE: Inflammatory Bowel Disease Management During the COVID-19 Outbreak: The Ten Do's and Don'ts from the ECCO-COVID Taskforce  Full Text
AUTHORS: Magro, F ; Rahier, JF; Abreu, C; MacMahon, E; Hart, A; van der Woude, CJ; Gordon, H; Adamina, M; Viget, N; Vavricka, S; Kucharzik, T; Leone, S; Siegmund, B; Danese, S; Peyrin Biroulet, L;
PUBLISHED: 2020, SOURCE: JOURNAL OF CROHNS & COLITIS, VOLUME: 14, ISSUE: Supplement_3
INDEXED IN: Scopus WOS CrossRef: 81
IN MY: ORCID
53
TITLE: Inflammatory Bowel Disease Reoperation Rate Has Decreased Over Time If Corrected by Prevalence  Full Text
AUTHORS: Santiago, M ; Magro, F ; Correia, L; Portela, F; Ministro, P; Lago, P; Trindade, E; Dias, CC ;
PUBLISHED: 2020, SOURCE: CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, VOLUME: 11, ISSUE: 9
INDEXED IN: Scopus WOS CrossRef: 3
IN MY: ORCID
54
TITLE: Is Faecal Calprotectin Important in Detecting Silent Gut Inflammation in Seronegative Arthropathies?  Full Text
AUTHORS: Fernando Magro ; Maria Manuela Estevinho;
PUBLISHED: 2020, SOURCE: JOURNAL OF CROHNS & COLITIS, VOLUME: 14, ISSUE: 7
INDEXED IN: Scopus WOS CrossRef: 1
IN MY: ORCID
55
TITLE: Is tofacitinib a game-changing drug for ulcerative colitis?
AUTHORS: Fernando Magro ; Maria Manuela Estevinho;
PUBLISHED: 2020, SOURCE: UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, VOLUME: 8, ISSUE: 7
INDEXED IN: Scopus WOS CrossRef: 11
IN MY: ORCID
56
TITLE: Microbiota-derived butyrate regulates intestinal inflammation: Focus on inflammatory bowel disease  Full Text
AUTHORS: Couto, MR; Goncalves, P; Magro, F ; Martel, F ;
PUBLISHED: 2020, SOURCE: PHARMACOLOGICAL RESEARCH, VOLUME: 159
INDEXED IN: Scopus WOS CrossRef: 87
IN MY: ORCID
57
TITLE: Newborn Congenital Abnormalities and Inflammatory Bowel Disease: Unveiling an Unexplored Relationship  Full Text
AUTHORS: Fernando Magro ; Maria Manuela Estevinho;
PUBLISHED: 2020, SOURCE: JOURNAL OF CROHNS & COLITIS, VOLUME: 14, ISSUE: 8
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
58
TITLE: Rapid test detection of anti-infliximab antibodies: performance comparison with three different immunoassays
AUTHORS: Catia Rocha; Paula Lago; Samuel Fernandes; Luis Correia; Francisco Portela; Ana Isabel Vieira; Marta Patita; Bruno Arroja; Paula Ministro; Catarina Alves; Claudia Camila Dias ; Fernando Magro ;
PUBLISHED: 2020, SOURCE: THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, VOLUME: 13
INDEXED IN: Scopus WOS CrossRef: 9
IN MY: ORCID
59
TITLE: Rehospitalization rates, costs, and risk factors for inflammatory bowel disease: a 16-year nationwide study
AUTHORS: Mafalda Santiago ; Fernando Magro ; Luis Correia; Francisco Portela; Paula Ministro; Paula Lago; Eunice Trindade; Claudia Camila Dias ;
PUBLISHED: 2020, SOURCE: THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, VOLUME: 13
INDEXED IN: Scopus WOS CrossRef: 1
IN MY: ORCID
60
TITLE: Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in Inflammatory Bowel Disease  Full Text
AUTHORS: Pedro Pinto-Lopes; Joana Afonso ; Rui Pinto-Lopes; Cátia Rocha; Paula Lago; Raquel Gonçalves; Helena Tavares De Sousa; Guilherme Macedo ; Cláudia Camila Dias ; Fernando Magro ;
PUBLISHED: 2020, SOURCE: Inflammatory Bowel Diseases, VOLUME: 26, ISSUE: 11
INDEXED IN: CrossRef: 16
IN MY: ORCID
Page 6 of 28. Total results: 274.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service